The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis
- PMID: 35911735
- PMCID: PMC9329538
- DOI: 10.3389/fimmu.2022.935160
The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis
Abstract
Acute-on-chronic liver failure (ACLF) is a group of clinical syndromes related to severe acute liver function impairment and multiple-organ failure caused by various acute triggering factors on the basis of chronic liver disease. Due to its severe condition, rapid progression, and high mortality, it has received increasing attention. Recent studies have shown that the pathogenesis of ACLF mainly includes direct injury and immune injury. In immune injury, cytotoxic T lymphocytes (CTLs), dendritic cells (DCs), and CD4+ T cells accumulate in the liver tissue, secrete a variety of proinflammatory cytokines and chemokines, and recruit more immune cells to the liver, resulting in immune damage to the liver tissue, massive hepatocyte necrosis, and liver failure, but the key molecules and signaling pathways remain unclear. The "danger hypothesis" holds that in addition to the need for antigens, damage-associated molecular patterns (DAMPs) also play a very important role in the occurrence of the immune response, and this hypothesis is related to the pathogenesis of ACLF. Here, the research status and development trend of ACLF, as well as the mechanism of action and research progress on various DAMPs in ACLF, are summarized to identify biomarkers that can predict the occurrence and development of diseases or the prognosis of patients at an early stage.
Keywords: ACLF; DAMPs; biological target molecules; danger hypothesis; inflammatory cytokine storm.
Copyright © 2022 Qiang, Liu and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The immunological roles in acute-on-chronic liver failure: An update.Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):403-411. doi: 10.1016/j.hbpd.2019.07.003. Epub 2019 Jul 5. Hepatobiliary Pancreat Dis Int. 2019. PMID: 31303562 Review.
-
Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure.Front Immunol. 2021 Jan 26;11:534731. doi: 10.3389/fimmu.2020.534731. eCollection 2020. Front Immunol. 2021. PMID: 33574809 Free PMC article. Clinical Trial.
-
Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure.Cells. 2020 Dec 8;9(12):2632. doi: 10.3390/cells9122632. Cells. 2020. PMID: 33302342 Free PMC article. Review.
-
The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing.J Immunol Res. 2022 Nov 2;2022:5091275. doi: 10.1155/2022/5091275. eCollection 2022. J Immunol Res. 2022. PMID: 36387424 Free PMC article. Review.
-
NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.Mol Immunol. 2020 Apr;120:179-186. doi: 10.1016/j.molimm.2020.01.011. Epub 2020 Mar 10. Mol Immunol. 2020. PMID: 32169738
Cited by
-
A clinical study of non-bioartificial liver DPMAES support system in hepatitis B-related acute-on-chronic liver failure.Sci Rep. 2024 Jan 20;14(1):1772. doi: 10.1038/s41598-024-52206-0. Sci Rep. 2024. PMID: 38245594 Free PMC article.
-
Metabolic Dysregulation and Metabolite Imbalances in Acute-on-chronic Liver Failure: Impact on Immune Status.J Clin Transl Hepatol. 2024 Oct 28;12(10):865-877. doi: 10.14218/JCTH.2024.00203. Epub 2024 Sep 19. J Clin Transl Hepatol. 2024. PMID: 39440217 Free PMC article. Review.
-
NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies.J Inflamm Res. 2025 Jun 24;18:8277-8294. doi: 10.2147/JIR.S532908. eCollection 2025. J Inflamm Res. 2025. PMID: 40585040 Free PMC article. Review.
-
Comparative analysis of monocyte-derived dendritic cell phenotype and T cell stimulatory function in patients with acute-on-chronic liver failure with different clinical parameters.Front Immunol. 2023 Dec 4;14:1290445. doi: 10.3389/fimmu.2023.1290445. eCollection 2023. Front Immunol. 2023. PMID: 38111573 Free PMC article.
-
Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLF.eGastroenterology. 2025 Mar 22;3(1):e100151. doi: 10.1136/egastro-2024-100151. eCollection 2025. eGastroenterology. 2025. PMID: 40134717 Free PMC article.
References
-
- Guideline for Diagnosis and Treatment of Liver Failure. Clin Hepatobiliary Dis (2019) 35(01):38–44. doi: 10.3760/cma.j.issn.1674-2397.2018.06.001 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials